Literature DB >> 11932845

Objective measurement of muscle strength in children with spastic diplegia after selective dorsal rhizotomy.

Cathleen E Buckon1, Susan Sienko Thomas, Gerald E Harris, Joseph H Piatt, Michael D Aiona, Michael D Sussman.   

Abstract

OBJECTIVES: To examine changes in isometric muscle strength at the elbow, knee, and ankle at 6 months and 1 year after selective dorsal rhizotomy (SDR) and to determine if SDR altered the frequency of muscle cocontraction.
DESIGN: Prospective outcome study of a consecutive sample.
SETTING: Children's hospital. PATIENTS: Ten children with spastic diplegia (7 independent and 3 dependent ambulators who used assistive devices) and 8 age-matched controls.
INTERVENTIONS: SDR; physical and occupational therapy; elbow, knee, and ankle measured for flexion and extension strength during three 10-second isometric contractions for each muscle group; and monitored cocontraction measured via muscle electrodes. MAIN OUTCOME MEASURES: Absolute and normalized values of isometric strength; and alterations in the frequency of cocontraction at 6 months and 1 year postoperatively.
RESULTS: Children with spastic diplegia showed significantly weaker knee extensors, ankle dorsiflexors, and ankle plantarflexors than age-matched controls. There were no significant differences in strength between the 2 groups in the elbow flexors, elbow extensors, and knee flexors. Isometric strength did not increase or decrease significantly after SDR. Cocontraction during knee extension was normalized after SDR, whereas cocontraction during ankle plantarflexion was unchanged by SDR in the majority of children.
CONCLUSION: SDR did not result in a significant decrease in muscle strength in ambulatory children with spastic diplegia. The normalization of the electromyographic patterns at the knee and not the ankle after SDR lends support to the premise that in children with cerebral palsy cocontraction is multifaceted, representing a volitional strategy to enhance control, as well as a disorder of the mechanisms that govern patterns of muscle activity. Copyright 2002 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation

Entities:  

Mesh:

Year:  2002        PMID: 11932845     DOI: 10.1053/apmr.2002.31202

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  5 in total

Review 1.  Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review.

Authors:  Amogh Kudva; Mickey E Abraham; Justin Gold; Neal A Patel; Julian L Gendreau; Yehuda Herschman; Antonios Mammis
Journal:  Neurosurg Rev       Date:  2021-04-19       Impact factor: 3.042

Review 2.  SELECTIVE DORSAL RHIZOTOMY IN CEREBRAL PALSY: SELECTION CRITERIA AND POSTOPERATIVE PHYSICAL THERAPY PROTOCOLS.

Authors:  Renata D'Agostini Nicolini-Panisson; Ana Paula Tedesco; Maira Rech Folle; Márcio Vinicius Fagundes Donadio
Journal:  Rev Paul Pediatr       Date:  2018-01-15

3.  Interventions to improve upper limb function for children with bilateral cerebral palsy: a systematic review.

Authors:  Véronique F P Plasschaert; Johanna E Vriezekolk; Pauline B M Aarts; Alexander C H Geurts; Cornelia H M Van den Ende
Journal:  Dev Med Child Neurol       Date:  2019-01-10       Impact factor: 5.449

4.  Energy consumption does not change after selective dorsal rhizotomy in children with spastic cerebral palsy.

Authors:  Nicole L Zaino; Katherine M Steele; J Maxwell Donelan; Michael H Schwartz
Journal:  Dev Med Child Neurol       Date:  2020-04-19       Impact factor: 5.449

5.  Whether the newly modified rhizotomy protocol is applicable to guide single-level approach SDR to treat spastic quadriplegia and diplegia in pediatric patients with cerebral palsy?

Authors:  Qijia Zhan; Xidan Yu; Wenbin Jiang; Min Shen; Shuyun Jiang; Rong Mei; Junlu Wang; Bo Xiao
Journal:  Childs Nerv Syst       Date:  2019-09-09       Impact factor: 1.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.